PM Meno-Care MenoPause Support

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

Zingiber officinale, Quantity: 5 mg (Equivalent: Zingiber officinale, Qty 25 mg); Trifolium pratense, Quantity: 75 mg (Equivalent: Trifolium pratense, Qty 300 mg); Actaea racemosa, Quantity: 80 mg (Equivalent: Actaea racemosa, Qty 400 mg); Angelica polymorpha, Quantity: 7.14 mg (Equivalent: Angelica polymorpha, Qty 50 mg); Salvia officinalis, Quantity: 5.45 mg (Equivalent: Salvia officinalis, Qty 30 mg; Equivalent: thujone, Qty 180 microgram)

Commercializzato da:

Pharmametics Products A Division of Max Biocare Pty Ltd

INN (Nome Internazionale):

Actaea racemosa,Angelica polymorpha,Salvia officinalis,Trifolium pratense,Zingiber officinale

Forma farmaceutica:

Capsule, hard

Composizione:

Excipient Ingredients: crospovidone; microcrystalline cellulose; croscarmellose sodium; titanium dioxide; colloidal anhydrous silica; erythrosine; sunset yellow FCF; calcium hydrogen phosphate dihydrate; magnesium stearate; purified water; Gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide

Via di somministrazione:

Oral

Indicazioni terapeutiche:

Maintain/support/regulate healthy menstrual cycle ; Decrease/reduce/relieve breast pain/tenderness associated with premenstrual tension ; Decrease/reduce/relieve symptoms of menopause ; Decrease/reduce/relieve hot flushes associated with menopause ; Decrease/reduce/relieve vaginal dryness

Dettagli prodotto:

Visual Identification: ;

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2007-06-19